Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Select Bioscience Reports | Multiplexed Diagnostics 2008 Market Report

Multiplexed Diagnostics 2008 Market Report

Multiplexed diagnostics are the wild west of medicine. Technology is established, regulation is limited and the number of new biomarkers exploding. First-movers are grabbing biomarker territories, combining independent measurements for efficiency and mining molecules for multivariate panels. All the while demand is high for improving diagnoses and predicting responses to treatment. The challenges, however, are uncertain reimbursement, unclear business models and ever-intensifying competition. On balance, though, the market is prosperous and is estimated to be more than $1.5 billion in 2007 and is projected to grow to more than $6 billion by 2013.

Successful navigation of this difficult terrain requires a detailed understanding of the market. Multiplexed Diagnostics 2008 explains the unmet needs, trends, regulations, competition, technologies and business strategies. The 260-page report includes a survey of more than 200 respondents, a detailed database of more than 135 commercial multiplexed diagnostics and a quantitative market model. In addition, the report comes with one hour of consulting (in the form of a conference call) with the lead author, Steven Bodovitz, Principal of BioPerspectives.

Published: May 2008

Pages: 260

Price

Single User Print Version $3,674.00

Electronic Site License (pdf + one print copy) $4,336.00

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions